LEXINGTON, Mass.– RainDance Technologies, Inc., the Digital Biology™ Company, today announced that it is collaborating with the Hôpital Saint-Louis in Paris, France and BGI in China, the world’s largest genomics institute, to discover new variants and confirm findings from a Rheumatoid Arthritis (RA) study conducted by researchers at the Hôpital Saint-Louis. The collaboration will utilize […]

Porvair Sciences has expanded its range of tissue culture treated clear bottomed microplates. Now available in 6-, 12-, 24- and 96-well formats – the bottom surface of Porvair tissue culture treated microplates is treated to enhance cellular attachment and growth in uniform layers. These high quality, clear bottomed plates allow cells grown on their bottom […]

AN DIEGO — Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced highlights of the Company’s 2011 performance and accomplishments, as well as preliminary activities and goals for the first part of 2012. Initial 2011 Performance Results Total revenue growth of approximately 23 percent year-over-year for 2011 (unaudited). Over […]

Anachem Ltd., a METTLER TOLEDO company (Luton, UK) is delighted to announce that it has now been awarded exclusive UK distribution rights for the novel range of molecular engineered reagents from KAPA Biosystems Inc., (Woburn, MA USA). Having become a trusted supplier to UK Life Science Research customers over the last 40 years, Anachem provides […]

WARREN, N.J. — Roka Bioscience announced today that it has secured $47.5 million in Series D financing. New investor Aisling Capital participated in the financing along with existing investors OrbiMed Advisors, New Enterprise Associates, Inc., and TPG Biotech. In conjunction with the financing, Josh Bilenker, M.D., Partner at Aisling Capital, will join Roka’s Board of […]

nanoTherics, a UK-based scientific medical research devices company, is pleased to announce launch of the magnefect-nano II DUO and the magnefect-LT DUO transfection systems which enable up to 192 transfection experiments to be performed in parallel. These new, compact devices offer gene transfection with improved efficiencies and cell viabilities, even with a range of difficult […]

OMAHA, Neb. – Transgenomic, Inc. (OTC/BB: TBIO) today announced that it has entered into a Convertible Promissory Note Purchase Agreement (the “Purchase Agreement”) in the aggregate amount of $3.0 million with entities (the “Investors”) associated with Third Security, LLC, a leading life sciences investment firm. “We are very pleased with the additional investment by Third […]

San Francisco, CA – Real Time Genomics, Inc., today announced that the Livestock Improvement Corporation (LIC) of New Zealand has signed a multi-year agreement to license RTG Investigator sequence analysis software for trait discovery in bovine genomes. Through an Early Access Program (EAP) relationship with LIC, Real Time Genomics extended its Bayesian variant analysis software […]

CAMBRIDGE, Mass. — Quanterix Corporation, a company enabling a new generation of molecular diagnostic tests based on its revolutionary Single Molecule Array (SiMoA™) technology, announced today a strategic investment and technology development agreement with In-Q-Tel (IQT), the independent strategic investment firm that identifies innovative technology solutions to support the missions of the U.S. Intelligence Community. […]